Mark J. Messing

1.9k citations
25 papers · 1.4k · 2 hit papers · h-index 12

Impact in

Papers in

Mark J. Messing

25 papers receiving 1.3k citations

Mark J. Messing's Hit Papers

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial 2023 · 238 citations
2380+2+4Years since publication100200300400

Peers

Mark J. Messing
Comparison fields: 5 of 55
  • Obstetrics and Gynecology 424
  • Reproductive Medicine 380
  • Oncology 288
  • Microbiology 23
  • Dermatology 29
Replace Shin Nishio with:
Shin Nishio Japan
Tadaaki Nishikawa Japan
Malaika W. Amneus United States
Ram Eitan Israel
Henric Malmström Sweden
Athina N. Christopoulou Greece
Michael K. Cheung United States
Alexandra Sebastianelli Canada
Kari Lassen Ring United States
Rossella De Cecio Italy
Mark J. Messing relative to Shin Nishio Japan Shin Nishio's profile →
Citations per field
00.5×5×11.5×
Shin Nishio · 1×
Citations per year

Countries citing papers authored by Mark J. Messing

Since Specialization
Citations

This map shows the geographic impact of Mark J. Messing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Messing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Messing more than expected).

Fields of papers citing papers by Mark J. Messing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Messing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Messing. The network helps show where Mark J. Messing may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Messing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Messing Line = papers co-authored together Mark J. Messing links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Hit paper breakdown →
2020414
2
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Hit paper breakdown →
2023238
3 2010189
4 199581
5 199669
6 201969
7 200968
8 199451
9 202335
10 198327
11 199225
12 199324
13 200211
14 202411
15 199310
16
Atypical glandular cells of undetermined significance and adenocarcinoma in situ: summoning colposcopic expertise?
19969
17 20048
18 19996
19 20196
20
Vaginal intraepithelial neoplasia III detected after hysterectomy for benign conditions.
19954

About Mark J. Messing

Mark J. Messing is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Surgery, Epidemiology and Microbiology, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Endometrial and Cervical Cancer Treatments (8 papers), Cervical Cancer and HPV Research (3 papers), Cancer and Skin Lesions (1 paper), Reproductive tract infections research (1 paper), Bacterial Infections and Vaccines (1 paper), Anesthesia and Pain Management (1 paper) and Gynecological conditions and treatments (1 paper). The work is most often cited by research in Obstetrics and Gynecology (424 citations), Reproductive Medicine (380 citations), Oncology (288 citations), Microbiology (23 citations) and Dermatology (29 citations). Mark J. Messing has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Donald G. Gallup, Kenneth C. Hancock, Robert J. Orlowski, Emmett V. Schmidt, Corina E. Dutcus, Vicky Makker, Carol A Aghajanian, Margarita Romeo, Marcia S. Brose and Allen Lee Cohn. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecological Cancer and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact